Sleep and Exercise Can Reprogram Mutant Blood Cells to Prevent Heart Disease

For decades, the medical consensus has treated acquired genetic mutations as fixed biological destiny. Once a somatic mutation occurs in the body's stem cells, lifestyle choices were thought to have little direct impact on the cellular behavior of those specific rogue clones. Patients could manage their systemic health, but the mutant cells themselves were considered beyond the reach of a morning jog or a good night's sleep.[1][3]

A landmark study published in Nature upends that assumption. Researchers have demonstrated that healthy sleep and regular exercise can directly suppress the growth and inflammatory behavior of mutated white blood cells—effectively forcing precancerous, disease-driving cells to behave like healthy ones. The discovery provides a molecular explanation for how lifestyle interventions protect the heart at the deepest genetic level.[1][2]

The research centers on a condition known as clonal hematopoiesis (CH). Every day, hematopoietic stem cells in the bone marrow divide to produce billions of new immune cells. Over a lifetime, the sheer volume of replication causes these stem cells to accumulate spontaneous DNA mutations.[2][3]

When a mutated stem cell begins to multiply faster than its healthy neighbors, it creates a disproportionate "clone" army of white blood cells. This phenomenon is rare in young people but becomes ubiquitous with age. Clonal hematopoiesis is detectable in roughly 25 percent of people over the age of 70, and in half of all individuals over 80.[2][3]

While CH was originally studied primarily as a precursor to blood cancers like leukemia, researchers made a startling discovery in the late 2010s: the primary danger of these mutant clones is actually cardiovascular. The rogue immune cells, particularly macrophages, are highly inflammatory. They swarm into blood vessels, exacerbating the buildup of atherosclerotic plaque and dramatically increasing the risk of fatal heart attacks and strokes.[3][7]

The new Nature study, led by researchers at the Cardiovascular Research Institute at the Icahn School of Medicine at Mount Sinai, asked a novel question: can behavioral interventions alter the trajectory of these specific genetic mutations? To find out, the team analyzed genetic and lifestyle data from nearly 83,000 participants in the UK Biobank and over 8,400 from the NIH's All of Us research program.[2]

The epidemiological data revealed a striking pattern. Individuals who engaged in moderate-to-vigorous physical activity had a significantly lower prevalence of CH clones in their blood. The finding suggested that exercise was somehow keeping the mutant stem cells in check, preventing them from dominating the bone marrow.[1][4]

To prove causality and uncover the underlying mechanism, the researchers turned to genetically engineered mice predisposed to atherosclerosis. They introduced specific CH mutations into the mice and subjected them to strictly controlled environments, comparing the effects of uninterrupted sleep versus sleep fragmentation, as well as exercise versus sedentary conditions.[3][4]

The results were highly specific and profoundly effective. In mice with mutations in the Jak2 or Tet2 genes, both sleep and exercise successfully curtailed the expansion of the mutant clones. The lifestyle interventions reduced the inflammatory signaling—specifically a pathway known as IL-1β—between bone marrow macrophages and stem cells, which ultimately shrank the atherosclerotic lesions in the arteries.[1][4]

The researchers traced the exact biological pathway for exercise. Physical activity activated PAC1+ neurons in the brain's locus coeruleus, prompting the release of peripheral noradrenaline. This neurotransmitter then signaled through specific receptors on the mutant macrophages, selectively repressing their inflammatory programming without altering the behavior of neighboring healthy cells.[1][4]

However, the study also revealed a crucial limitation: the benefits are entirely mutation-dependent. While sleep and exercise neutralized the cardiovascular risks of Jak2 and Tet2 mutations, they had absolutely no effect on clones driven by mutations in the Dnmt3a or Trp53 genes. The mutant cells in those pathways continued to drive plaque formation regardless of the mice's lifestyle.[1][3]

"Adequate sleep or exercise can reverse the atherosclerosis risk, but it's different for the different gene variants," noted Dr. Alan Tall, a cardiovascular researcher at Columbia University who reviewed the findings. This discovery introduces the concept of precision lifestyle medicine, where the efficacy of a behavioral intervention depends entirely on the patient's specific genetic architecture.[3]

The findings also help contextualize conflicting data in the broader field of oncology and cardiology. A 2025 study published in JACC: CardioOncology analyzed cancer patients with CH and found that while exercise reduced overall mortality, it did not shrink the size of the mutant clones. The Mount Sinai team's discovery that lifestyle interventions only constrain specific mutations—and that they can reduce plaque inflammation even when clone size remains stable—helps explain these previously observed discrepancies.[6]

For the millions of older adults unknowingly harboring these mutations, the implications are profoundly empowering. "Our findings reveal that CH mutant cells are malleable and selectively responsive to lifestyle behavior in a way that can mitigate atherosclerotic risk," said Dr. Cameron McAlpine, the study's senior author.[2][5]

While patients cannot erase the somatic mutations accumulating in their bone marrow as they age, they are not defenseless against them. By maintaining regular physical activity and protecting their sleep architecture, individuals can actively suppress the most dangerous genetic drivers of cardiovascular aging, forcing mutant cells to behave like healthy ones.[2][3]